Real Men Wear Pink Swing Fore A Cure Golf Tournament Raises Over $36,000

Winning 4some

Real Men Wear Pink winning foursome: Sugiyo USA group, comprised of Cory Adcock, Matt Roldan, Travis Rosia and Blake Couick

CHARLOTTE, NC (News Release) — The American Cancer Society (ACS) held its annual Real Men Wear Pink Swing Fore A Cure golf tournament on October 17 at Emerald Lake Golf Course in Matthews. Real Men Wear Pink (RMWP) is an exclusive group of corporate and community leaders who rise to the challenge by wearing pink and raising money to help end breast cancer throughout October.

“What a fantastic day. Our Swing Fore A Cure completely exceeded my expectations,” said David Hess, Harris Teeter’s senior director of meat and seafood and chair of Charlotte’s Real Men Wear Pink. “We sold out of sponsorships, and I am extremely appreciative of all the work that was put forth to raise more than $36,000 for breast cancer research. Many of our Real Men Wear Pink ambassadors and supporters participated in the Swing Fore A Cure golf event, and I am proud to be associated with this fine group.”

The winning team from Sugiyo USA group, comprised of Cory Adcock, Matt Roldan, Travis Rosia and Blake Couick, with a score of 57.

Three Korn Ferry professional golfers (Trace Crowe, David Kocher and Taylor Dickson) added a power play element to the event through “Purchase A Pro” as the tour golfers offered to drive (tee-off) on behalf of participants at three long drives to raise additional funds.

The American Cancer Society is the leading cancer-fighting organization with a vision of ending cancer as we know it, for everyone. While breast cancer deaths have declined steadily in the last three decades, experts say Black women are still less likely to be diagnosed than white women and are 41% more like to die from breast cancer.

  • Know your guidelines. ACS recommends breast cancer screening for women at average risk beginning at age 45, with the option to begin at age 40. More information is available on
  • Breast cancer is the most commonly diagnosed cancer among US women after skin cancer.
  • It is the second leading cause of cancer death among women overall, after lung cancer, but the leading cause of cancer death among Black and Hispanic women.
  • In 2022, approximately 287,850 women in the US will be diagnosed with invasive breast cancer and 43,250 will die from the disease.
  • In total, the death rate dropped by 43% between 1989 and 2020, translating to more than 460,000 fewer breast cancer deaths during that time. This progress is due to earlier detection through screening and increased awareness, as well as advances in treatment.
  • ACS is currently investing more than $69 million in breast cancer-specific research through 153 grants (as of September 2022.)
  • In the last 30 years alone, ACS has invested more than $422 million in breast cancer research.